Accelerating evidence indicates that TIPE2 inhibits the development of a variety of malignant tumors by suppressing cell proliferation (17, 18), inducing cancer cell apoptosis (19), inhibiting tumor migration (20, 21), and promoting antitumor immune responses mediated by CD8+ T and natural killer (NK) cells (22). This evidence concerns the gene CD8A and cancer.